WhiteHill Life Sciences Announces Final US Patent Application for Stannous Fluoride Sugar Alcohol Solid Solutions and the US "National Stage" Filings for the Pending Pate
The Stannous Fluoride patent transforms shelf stability issues and off-putting tastes that are problematic to good user compliance through our discovery and hedonics expertise. The Synergistic Compositions and Methods of Achieving Homeostasis patent relates to a composition of matter useful for treating homeostatic malfunction by creating synergies that increase the nature and function over any single ingredient.
STAFFORD, Texas, May 17, 2019 /PRNewswire-PRWeb/ -- Ronald Butler, MBA CEO of WhiteHill Life Sciences announces additional patent filings from inventors Dr. Dale Brown, PhD and Dr. Ira Hill, PhD.
WhiteHill has for over 30 years provided for major consumer products brands oral care products including premium floss, foundational bases for toothpastes, mouth rinses and other oral care products currently sold around the world.
The advancements in these two filings push total intellectual properties from the WhiteHill science team to more than 50 since its founding in 1986.
Regarding the Stannous Fluoride Sugar Alcohol final filing, "This unique, surprisingly more stable formulation of stannous fluoride, which does not resort to Stannous ion de-activating ingredients for control of negative taste and feel, is exceptionally effective not only for treatment of periodontal disease, but also for the treatment of various oral sores like aphthous ulcers, yeast infections such as thrush and the terrible oral pain resulting from other disorders.
Instead of the strongly astringent, metallic or green persimmon mouth feeling and taste as is generally experienced from traditional Glycerin/Stannous Fluoride solutions, products formulated under this technology taste quite good", said Dr Hill, an expert in hedonic perception.
Additionally, the Synergistic Homeostasis Compositions and Methods pending US patent, was recently published by the World Intellectual Property Organization. ["WIPO" is one of the 15 specialized agencies of the United Nations. It was created in 1967 "to encourage creative activity, to promote the protection of intellectual property throughout the world"] "This breakthrough technology delivers efficacy via a broad range of delivery methods including topical creams, lozenges, tablets, gels, rinses, sprays and other methods. We are no longer limited to oral care application but can now address such areas as skin care and inflammation", the WhiteHill Creative Team inventors emphasize.
"Synergy is gaining a greater result than from a one plus one equals two result. We are encouraged by research and development that our synergistic compositions may improve efficacy by a numerical factor greater than the sums of the parts," adds Dr. Hill.
Further, Dr. Brown explains that "reducing a broad spectrum of damaging inflammatory conditions can relieve pain and debilitating effects of many ailments such as sunburn, or muscular and joint pains, and serious skin conditions such as psoriasis, insect stings and continual itching, side effects of cancer treatment, and autoimmune diseases like Sjogren's, Crohn's, Irritable Bowel Syndrome (IBS).
We have been able to devise an effective Cannabinoid product (CannabiRelief™) without the use of hemp or marijuana thus creating a THC free, non-psychoactive and completely legal use".
The body of the patent contains many actual case studies on patients suffering such conditions.
WhiteHill will be licensing specific human and animal applications of the know how that comes with these filings and allied WhiteHill technology to interested entities in the HABA, Personal Care, Veterinary and Pharmaceutical arenas.
Interested parties can also visit the WhiteHill patent page at: http://www.WHLifeSciences.com, or contact WhiteHill's CEO Ron Butler at inquiries(at)WHLifeSciences(dot)com
See our most recent consumer products story on http://www.hydralief.com
SOURCE WhiteHill Life Sciences
Share this article